Early research (Phase 1)UnknownNCT04836871What this trial is testingDouble Filtration Plasmapheresis Combined With ChemotherapyWho this might be right forMultiple Myeloma Fuling Zhou 20
Testing effectiveness (Phase 2)Ended earlyNCT00681044What this trial is testingHD Melphalan and SCT in Patients With IGDD or LCDDWho this might be right forMultiple Myeloma Boston Medical Center 5
Large-scale testing (Phase 3)Study completedNCT04583995What this trial is testingA Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United KingdomWho this might be right forSARS-CoV-2 InfectionCOVID-19 Novavax 15,185
Not applicableStudy completedNCT05239923What this trial is testingCOVID19 Oral Vaccine Consisting of Bacillus Subtilis SporesWho this might be right forCOVID-19 Pneumonia DreamTec Research Limited 35
Not applicableLooking for participantsNCT06690593What this trial is testingCharacteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal GammopathyWho this might be right forMonoclonal Gammopathy of Undetermined Significance (MGUS)Intestinal FloraMultiple Myeloma+1 more Zhujiang Hospital 2,990
Large-scale testing (Phase 3)Study completedNCT04611802What this trial is testingEvaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2Who this might be right forSARS-CoV InfectionCovid19 Novavax 33,000
Large-scale testing (Phase 3)Study completedNCT05231590What this trial is testingImmunogenicity and Safety of the SpikoGen COVID-19 Vaccine in Children Aged 5 to <12 Years and 12 to <18 Years Compared With Adults Aged 18 to 40 YearsWho this might be right forCOVID-19 Cinnagen 581
Not applicableStudy completedNCT05251896What this trial is testingPlasma-free Replacement in Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Zhongnan Hospital 119
Testing effectiveness (Phase 2)Study completedNCT01998633What this trial is testingReduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)Who this might be right forHemophagocytic LymphohistiocytosisChronic Active Epstein-Barr Virus InfectionChronic Granulomatous Disease+3 more Medical College of Wisconsin 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT07111338What this trial is testingTelitacicept for PGNMID: A Single-Arm StudyWho this might be right forProliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits Peking University First Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT00464178What this trial is testingA Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Hackensack Meridian Health 7
Post-approval studies (Phase 4)Looking for participantsNCT07730450What this trial is testingLearn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of AgeWho this might be right forCOVID-19 Vaccines BioNTech SE 200
Very early researchNot Yet RecruitingNCT07389499What this trial is testingA Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney DiseasesWho this might be right forIgA Nephropathy (IgAN)Membranous NephropathyANCA-associated Vasculitis (AAV)/ANCA-associated Glomerulonephritis (AAGN)+2 more Grit Biotechnology 30
Testing effectiveness (Phase 2)Study completedNCT05112848What this trial is testingEvaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS-CoV-2 (COVID-19)Who this might be right forSARS-CoV-2 Infection Novavax 384
Testing effectiveness (Phase 2)WithdrawnNCT01234974What this trial is testingIGF-1 Inhibitor Pasireotide Lar in Combination With the m-TOR Inhibitor EverolimusWho this might be right forMultiple Myeloma Milton S. Hershey Medical Center
Testing effectiveness (Phase 2)UnknownNCT05238454What this trial is testingA Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 VaccineWho this might be right forCOVID-19SARS-CoV-2 Infection Sinocelltech Ltd. 600
Large-scale testing (Phase 3)UnknownNCT03578341What this trial is testingOral Colostrum and Its Effect on Immune SystemWho this might be right forImmune System DiseasesPremature Infant DiseaseImmunoglobulin Deficiency Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes 96
Not applicableLooking for participantsNCT06065852What this trial is testingNational Registry of Rare Kidney DiseasesWho this might be right forAdenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more UK Kidney Association 35,000
Early research (Phase 1)UnknownNCT04982068What this trial is testingPhase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19Who this might be right forCOVID-19 Shanghai Zerun Biotechnology Co.,Ltd 72
Testing effectiveness (Phase 2)UnknownNCT02519114What this trial is testingHaploidentical Bone Marrow Stem Cell Transplantation in Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Maastricht University Medical Center 24